Gastrointestinal

Mortality high for people with comorbid myocardial infarction and epilepsy

Safety profile similar to other trials, with six in 10 sustaining medication overuse headache remission over six months

Clinicians remain a preferred source, but were less often the actual source

Stone fragmentation occurred in 88 percent of cases, with most patients receiving no or minor analgesia

Improvement seen in overall structure preservation rate, orbit preservation rate, and skull base preservation rate

Findings seen despite similar use of emergency medical services transport

By Robin Foster HealthDay Reporter WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- Women with early-stage breast cancer may now take Kisqali, a medication already approved...

By Dennis Thompson HealthDay Reporter WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these...

Reduced risk for Alzheimer disease, vascular dementia, and Parkinson disease seen with SGLT2i use in type 2 diabetes

In fully adjusted model, greater adherence linked to reduced risk for cognitive impairment in women, but not men

Approval is for new, first-line biologic treatment of eczema that is not well controlled with topicals in people 12 years and older

Significant increase seen in prepandemic EMS encounters, followed by immediate, significant increase with pandemic interruption

Habitual caffeine or coffee intake, especially at moderate levels, linked to lower risk for new-onset CM

AF patients became relatively younger over time, were less likely to be female or White, and were more likely to have HTN, diabetes

Estimated percentage eligible ranges from 24 to 62 percent depending on eligibility criteria used